AD 6th Oct issue | Seite 28

28 HOW TO TREAT : ACUTE KETOACIDOSIS

28 HOW TO TREAT : ACUTE KETOACIDOSIS

6 OCTOBER 2023 ausdoc . com . au
Box 1 . Predisposing ( ketosisprone ) conditions associated with an increased risk of euglycaemic ketoacidosis
• Diabetes ( type 1 , type 2 or gestational diabetes ).
• Treatment with sodium-glucose transporter 2 ( SGLT2 ) inhibitors .
• Pregnancy .
• Severe restriction of dietary carbohydrate intake .
• Starvation .
• Severe catabolic illness ( eg , septic ketoacidosis , pancreatitis , following major surgery ).
• Severe liver disease ( eg , cirrhosis , liver failure ).
• Chronic alcoholic abuse .
• Cocaine use .
• Inherited metabolic disease ( eg , glycogen storage disease , maple syrup urine disease ).
Box 2 . Common trigger events for ketoacidosis
Figure 1 . The risk of DKA .
• Omission of insulin therapy , reduction in insulin dose or inadequate dosing .
• Insulin pump failure , occlusion or infusion site failure .
• Prolonged nausea and vomiting .
• Infections ( eg , pneumonia , COVID-19 , urinary tract infections , sepsis ).
• Eating disorders , diabulimia .
• Binge drinking .
• Pregnancy .
• Very low-carbohydrate / food intake or prolonged fasting .
• Extreme physiological stress ( eg , dehydration , blood loss , major surgery , trauma , myocardial infarction , pancreatitis ).
• Initiation of certain medications ( corticosteroids , pentamidine , check-point inhibitors , antipsychotic drugs , illicit drugs ).
( EKA ), and is a rare complication
such as severe illness , extended fast-
the characteristic ‘ rotting apple ’ or
Treatment with SGLT2 inhibitors
type 1 diabetes ( that is , before insu-
of various different severe metabolic
ing ( for example , gastrointestinal
‘ nail polish ’ breath odour of a patient
in individuals with type 2 diabetes
lin is started ). Indeed , DKA can be
stressors in susceptible individuals
illness , acute abdomen ), may rarely
with ketoacidosis .
causes glycosuria ( glucose wasting )
a presenting feature in up to half
( see box 1 ).
precipitate ketoacidosis , especially in
Most DKA events are sudden .
that induces comparable metabolic
of Australian children with type 1
People with diabetes can also
women with gestational or pre-exist-
Although a profound deficiency of
changes to a low-carbohydrate diet ,
diabetes . 12
experience EKA . In fact , when put
ing diabetes .
insulin is the predisposing state , DKA
including reduced insulin and ele-
DKA can also occur in patients
under the same metabolic stress ( for
EKA has also been described fol-
is invariably associated with a sig-
vated glucagon concentrations .
with type 1 diabetes because of
example , pregnancy , starvation , sep-
lowing excessive chronic alcohol
nificant intercurrent illness or trig-
On average , blood ketone levels
non-adherence or omission of insu-
sis ), EKA is more common in diabetic
intake , often during withdrawal or
ger event ( see box 2 ), that results in
are approximately double in diabetic
lin therapy ( for example , missed
individuals .
because of symptoms preventing
increased release of counter-regu-
patients treated with SGLT2 inhibi-
insulin doses , insulin pump failure ,
EKA is also observed following the use of SGLT2 inhibitors in people with type 2 diabetes . 15 Indeed , SGLT2 inhibitors are contraindicated
food intake such as nausea , vomiting or abdominal pain . 5
EKA may rarely occur in non-diabetic patients with prolonged and
latory ( or stress ) hormones such as glucagon , corticosteroids , catecholamines , leptin and growth hormones . These hormones further oppose the
tors compared with other therapies . 18 These levels are similar to the magnitude of increase observed during pregnancy , where the metabolic
or diabulimia [ an eating disorder where those with type 1 diabetes intentionally give themselves less insulin than they need or stop
in patients with type 1 diabetes , spe-
severely reduced carbohydrate / food
actions of ( inadequate ) insulin and
activity of the placenta and develop-
using their insulin in order to lose
cifically because of the increased risk of EKA in this setting . 16 Recent clinical trials in patients with type 2 diabetes suggest that treatment with SGLT2 inhibitors may double the risk of EKA . 15 Nonetheless , because so many patients with type 2 diabetes are now receiving SGLT2 inhibitors as part of their ongoing care , SGLT2
intake ( for example , prolonged fasting , starvation , illness , gastrointestinal disorders ) because of increased ketogenesis combined with dehydration . 5 For example , EKA has also been reported after bariatric surgery . 17
PATHOGENESIS
KETONES are naturally generated
markedly augment ketogenesis . Intercurrent illnesses are an unavoidable part of normal life . Even in adults with long-standing established type 1 diabetes , such events can sometimes sporadically trigger DKA , even if there is no history of DKA events , poor glucose control or risk-taking behaviour .
ing baby , rather than the urine , provides the metabolic sink for glucose losses . 4 Again , pregnancy-related ketosis is distinct from pathophysiological ketoacidosis . However , both pregnancy and SGLT2 inhibition are ‘ ketosis-prone ’ states ( see box 1 ) and risk factors for EKA , given the right ( or more correctly , the wrong )
weight ]).
Most patients with established type 1 diabetes develop DKA during intercurrent infections that suddenly increase their insulin resistance , while at the same time hypermetabolism , volume depletion and vasodilation associated with infections can amplify ketogene-
inhibitors have become a leading
from fatty acids by the liver as an
Blood ketone levels are naturally
trigger .
sis in some patients . Concurrently ,
cause of EKA . There has been only one recorded event of ketoacidosis in participants without diabetes receiving an SGLT2 . 15
alternative mitochondrial fuel source for metabolically demanding tissues , such as the brain , the heart and skeletal muscle . Ketone production
elevated when following a diet low in carbohydrate ( for example , a “ keto ” diet that is high in fat and very low in carbohydrate , see figure 3 ). This
RISK FACTORS AND TRIGGERS
KETOACIDOSIS is almost always
patients often reduce their insulin dose because of the perceived risk of hypoglycaemia when they feel unwell and are not eating and
EKA is a very rare complication of
increases as insulin levels fall and
is known as physiological ketosis
the result of a trigger event ( see
drinking . Finally , in some adults
pregnancy . 4 Pregnancy naturally acts to amplify ketone production , and
glucagon levels rise in the fasting / starved state as glycogenolysis by the
or nutritional ketosis , which actually has the goal of increasing serum
box 2 ) in susceptible individuals . The most common trigger event
with type 1 diabetes , binge drinking can supress gluconeogenesis and
ketone levels are usually higher in
liver is exhausted ( see figure 2 ).
ketone concentrations of above
in patients with type 1 diabetes is
increase the demand for an addi-
pregnancy because of systemic insu-
The major ketones , acetoacetate
0.5mmol / L . This state is very distinct
severe volume depletion / dehydra-
tional ( ketone ) fuel substrate .
lin resistance and the large metabolic
and β-hydroxybutyrate , are organic
from pathophysiological ketoacidosis
tion due to severe hyperglycaemia ,
Importantly , these same trig-
demands of the developing fetus and
acids that in high enough levels cre-
( see figure 4 ), where levels of ketone
which drives a strong counterreg-
ger events are also implicated in
placenta , particularly in the third trimester . However , intercurrent dia-
ate the ‘ high anion gap ’ metabolic acidosis characteristic of ketoacidosis .
concentrations are much higher and fail to be offset by renal compensa-
ulatory response and unimpeded ketogenesis . This is most likely at
most cases of EKA in ketosis-prone settings ( see box 1 ). For example ,
betes and / or during trigger events
Acetone is also generated , creating
tion of acidosis .
the first presentation of new-onset
severe COVID-19 infection
PAGE 30